Shanghai RAAS Blood Products Co Ltd Class A (002252) — Cash Flow Reinvestment Rate
Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Cash Flow Reinvestment Rate of 0.41x as of March 2025, reinvesting CN¥317.67 Million (capex CN¥62.51 Million plus investments CN¥255.16 Million) from operating cash flow of CN¥775.56 Million. Explore Shanghai RAAS Blood Products Co Ltd Clas capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai RAAS Blood Products Co Ltd Class A Cash Flow Reinvestment Rate (2005–2023)
Historical reinvestment intensity for Shanghai RAAS Blood Products Co Ltd Class A across 18 annual periods. Also explore 002252 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai RAAS Blood Products Co Ltd Class A (2005–2023)
Year-by-year capital reinvestment analysis for Shanghai RAAS Blood Products Co Ltd Class A. For live market cap and broader valuation context, see 002252 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.49x | CN¥1.12 Billion | CN¥2.28 Billion | CN¥450.80 Million | ▼ -27.5% |
| 2022 | 0.68x | CN¥1.17 Billion | CN¥1.73 Billion | CN¥225.73 Million | ▲ +8.0% |
| 2021 | 0.63x | CN¥814.12 Million | CN¥1.29 Billion | CN¥204.61 Million | ▲ +17.7% |
| 2020 | 0.53x | CN¥624.78 Million | CN¥1.17 Billion | CN¥251.76 Million | ▲ +172.1% |
| 2019 | 0.20x | CN¥171.43 Million | CN¥872.69 Million | CN¥154.84 Million | ▼ -94.6% |
| 2018 | 3.66x | CN¥959.60 Million | CN¥262.50 Million | CN¥156.94 Million | ▼ -42.4% |
| 2017 | 6.35x | CN¥1.71 Billion | CN¥268.76 Million | CN¥157.84 Million | ▲ +273.3% |
| 2016 | 1.70x | CN¥1.08 Billion | CN¥638.22 Million | CN¥147.49 Million | ▲ +791.5% |
| 2015 | 0.19x | CN¥145.39 Million | CN¥762.42 Million | CN¥145.39 Million | ▲ +36.6% |
| 2014 | 0.14x | CN¥65.06 Million | CN¥465.96 Million | CN¥65.06 Million | ▼ -75.4% |
| 2012 | 0.57x | CN¥149.70 Million | CN¥263.46 Million | CN¥149.70 Million | ▼ -42.8% |
| 2011 | 0.99x | CN¥176.80 Million | CN¥178.03 Million | CN¥176.80 Million | ▲ +122.9% |
| 2010 | 0.45x | CN¥89.21 Million | CN¥200.21 Million | CN¥89.21 Million | ▼ -15.2% |
| 2009 | 0.53x | CN¥60.99 Million | CN¥116.01 Million | CN¥60.99 Million | ▲ +93.6% |
| 2008 | 0.27x | CN¥29.23 Million | CN¥107.64 Million | CN¥29.23 Million | ▲ +95.1% |
| 2007 | 0.14x | CN¥24.46 Million | CN¥175.71 Million | CN¥24.46 Million | ▼ -38.3% |
| 2006 | 0.23x | CN¥12.08 Million | CN¥53.58 Million | CN¥12.08 Million | ▼ -43.8% |
| 2005 | 0.40x | CN¥21.69 Million | CN¥54.02 Million | CN¥21.69 Million | — |